FDA 483 - AGC WAKASA CHEMICALS CO., LTD. - November 02, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of AGC Wakasa Chemicals Co., Ltd. in Obama, Fukui, Japan, an API and intermediate manufacturer, revealed significant deficiencies across its quality, production, and laboratory systems. The firm failed to adequately investigate out-of-specification results, ensure proper training for visual inspection personnel, and maintain adequate control over batch records. Additionally, the Quality Unit did not approve scientifically justified and validated analytical procedures for microbial testing of water used in manufacturing.
ID · 357ea66d-1020-486f-a736-14f9485e2994